Sig Brokerage, LP Tg Therapeutics, Inc. Transaction History
Sig Brokerage, LP
- $1.87 Trillion
- Q4 2024
A detailed history of Sig Brokerage, LP transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Sig Brokerage, LP holds 8,000 shares of TGTX stock, worth $247,520. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,000Holding current value
$247,520% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding TGTX
# of Institutions
370Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$483 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$352 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$285 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$98.8 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$86.4 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.49B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...